• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Pacira Pharmaceuticals, Inc. (PCRX)

    -NasdaqGS
    92.47 Up 1.47(1.62%) Dec 17, 4:00PM EST
    |After Hours : 92.48 Up 0.01 (0.01%) Dec 17, 4:41PM EST
    Add to Portfolio
    Prev Close:91.00
    Open:91.00
    Bid:N/A
    Ask:110.00 x 1000
    1y Target Est:109.88
    Beta:2.24
    Earnings Date:Feb 23 - Feb 27 (Est.)
    Day's Range:89.06 - 92.72
    52wk Range:48.27 - 112.00
    Volume:438,786
    Avg Vol (3m):591,100
    Market Cap:3.33B
    P/E (ttm):N/A
    EPS (ttm):-0.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PCRX

    Comparison

    Symbol% ChgMkt Cap
    PCRXUp 1.62%3.33B
    ALKSUp 6.82%8.18B
    DRRXUp 5.79%98.61M

    Key Statistics

    Forward P/E (1 yr):35.84
    P/S (ttm):19.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.26
    Quarterly EPS Est (Dec-14) :0.24
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products primarily for use in hospitals and ambulatory surgery centers worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback